Currently, certain drugs, including insulin sensitizers, statins, vitamin E, ursodeoxycholic acid and betaine, are proven to be beneficial for the clinical treatment of NAFLD. The gene discussed is INS; the disease is metabolic dysfunction-associated steatotic liver disease.